Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants
Fatemeh Rahimi-Sakak, Mahsa Maroofi, Jamal Rahmani, et al.
BMC Cardiovascular Disorders (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia
Georgiana Cabău, Tania O. Crişan, Viola Klück, et al.
Immunological Reviews (2019) Vol. 294, Iss. 1, pp. 92-105
Open Access | Times Cited: 195
Gut bacterial metabolism contributes to host global purine homeostasis
Kazuyuki Kasahara, Robert L. Kerby, Qijun Zhang, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 1038-1053.e10
Open Access | Times Cited: 92
INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"
И. И. Дедов, Marina V. Shestakova, G. А. Melnichenko, et al.
Obesity and metabolism (2021) Vol. 18, Iss. 1, pp. 5-99
Open Access | Times Cited: 98
The Epidemiology and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Population Genetics Secondary Database Analysis
Faven Butler, Ali Alghubayshi, Youssef M. Roman
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 231-231
Open Access | Times Cited: 84
Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update
Claudio Borghi, Justyna Domienik‐Karłowicz, Andrzej Tykarski, et al.
Cardiology Journal (2021) Vol. 28, Iss. 1, pp. 1-14
Open Access | Times Cited: 67
Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
Tzong‐Shyuan Lee, Tse-Min Lu, Chia‐Hui Chen, et al.
Redox Biology (2021) Vol. 46, pp. 102108-102108
Open Access | Times Cited: 63
Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?
Asmaa Elrakaybi, Katharina Laubner, Qian Zhou, et al.
Molecular Metabolism (2022) Vol. 64, pp. 101549-101549
Open Access | Times Cited: 57
Gender differences in all-cause and cardiovascular mortality among US adults: from NHANES 2005–2018
Ying Lv, Xiaodi Cao, Kai Yu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 10
Impact of Hyperuricemia on Incident Hypertension When Hypertension Definition Changes From 140/90 to 130/80 mmHg in a Large Taiwanese Population Follow‐Up Study
Yi‐Hsueh Liu, Wei‐Yu Su, Chih‐Yi Lin, et al.
Journal of Clinical Hypertension (2025) Vol. 27, Iss. 2
Open Access | Times Cited: 1
Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
Gerwyn Morris, Basant K. Puri, Lisa Olive, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 70
Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid
A Tedeschi, Piergiuseppe Agostoni, Beatrice Pezzuto, et al.
European Journal of Preventive Cardiology (2020) Vol. 27, Iss. 2_suppl, pp. 35-45
Open Access | Times Cited: 63
Why Does Hyperuricemia Not Necessarily Induce Gout?
Wei‐Zheng Zhang
Biomolecules (2021) Vol. 11, Iss. 2, pp. 280-280
Open Access | Times Cited: 53
The serum uric acid-to-high-density lipoprotein cholesterol ratio is a predictor for all-cause and cardiovascular disease mortality: a cross-sectional study
Zhanbin Li, Qiaoran Liu, Zhenyu Yao
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 7
Uric acid to high-density lipoprotein cholesterol ratio predicts cardiovascular mortality in patients on peritoneal dialysis
Ruihua Liu, Yuan Peng, Haishan Wu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2020) Vol. 31, Iss. 2, pp. 561-569
Closed Access | Times Cited: 41
The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems
Davide Agnoletti, Arrigo F.G. Cicero, Claudio Borghi
Cardiology Clinics (2021) Vol. 39, Iss. 3, pp. 365-376
Closed Access | Times Cited: 35
Hyperuricemia in Psoriatic Arthritis: Epidemiology, Pathophysiology, and Clinical Implications
Cesare Tripolino, Jacopo Ciaffi, Piero Ruscitti, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 33
The Interaction Between Dietary Fructose and Gut Microbiota in Hyperuricemia and Gout
Xinyu Fang, Liang-wei Qi, Haifeng Chen, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 27
Elevated serum uric acid was associated with pre-inflammatory state and impacted the role of HDL-C on carotid atherosclerosis
Xiangming Hu, Jieliang Liu, Wei Li, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 7, pp. 1661-1669
Closed Access | Times Cited: 25
Impact of Hyperuricemia and Urate-Lowering Agents on Cardiovascular Diseases
Franklin Sosa, Mohammed Shaban, José López, et al.
Clinical Medicine Insights Cardiology (2024) Vol. 18
Open Access | Times Cited: 5
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis and Progression of Genetic Diseases of the Connective Tissue
Gustavo Egea, Francesc Jiménez‐Altayó, Victoria Campuzano
Antioxidants (2020) Vol. 9, Iss. 10, pp. 1013-1013
Open Access | Times Cited: 33
Role of Vitamin C in Prophylaxis and Treatment of Gout—A Literature Review
Olga Brzezińska, Filip Styrzyński, Joanna Makowska, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 701-701
Open Access | Times Cited: 32
Association of hyperuricemia with cardiovascular diseases: current evidence
Steven G. Chrysant
Hospital Practice (2023) Vol. 51, Iss. 2, pp. 54-63
Closed Access | Times Cited: 13
Gout and hyperuricaemia: modifiable cardiovascular risk factors?
Michel Burnier
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 13
Small molecule mediators of host-T. cruzi-environment interactions in Chagas disease
Godwin Kwakye-Nuako, Caitlyn E. Middleton, Laura‐Isobel McCall
PLoS Pathogens (2024) Vol. 20, Iss. 3, pp. e1012012-e1012012
Open Access | Times Cited: 4
Uric acid and cardiovascular diseases: a reappraisal
Akruti Patel Prabhakar, Angel López‐Candales
Postgraduate Medicine (2024) Vol. 136, Iss. 6, pp. 615-623
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top